MBL2 and breast carcinoma: CD95 and MBL2, two immune function genes, the promoter single nucleotide polymorphisms (SNPs) of CD95 (rs2234767) and MBL2 (rs7096206) are associated with grade 3 infection following treatment of breast cancer with cytotoxic therapy [89].